Correct - Elanco wants the world wide rights. That's going to...

Correct - Elanco wants the world wide rights.

That's going to cost big dollars - especially after positive clinical results.

There are 45,000 veterinary surgeries on the USA alone. Worldwide?

PharmAust will be looking at some very substantial income when all of this is finalized.

My guess is that the MPL will be used either on its own as a cheap alternative to chemotherapy or with chemotherapy, and after for the life of the canine. This being the case there are millions of canines world wide who could be placed on MPL, until they pass away.

That is where I feel the big dollars are and that I think is where PharmAust will reap massive royalties, under license from Elanco.

As for the dollar value - anyone's guess. But for a company trading over 17 billion annually, you can bet it will be in the hundreds of millions, for them to even be interested and participate in this exercise. They are not the sort of company to have grown to this size from wasting there time.

Moving along then we have the human trials.......

As always
Best
MM